29 August 2022 in Obesity and metabolism
The medical and social significance of cardiovascular diseases remains high. One of the factors that determine cardiovascular risks is metabolic syndrome. As a result of excessive accumulation of lipid and carbohydrate metabolism products in metabolic syndrome, oxidative (oxidative) stress develops. The article considers both domestic and foreign scientific studies, which highlight various aspects of the influence of reactive oxygen and nitrogen species, as well as other free radicals on the formation of oxidative stress in pathological conditions that are part of the metabolic syndrome complex. This describes the mechanisms of the formation of chronic inflammation through excessive secretion of pro-inflammatory cytokines and adipokines, activation of the transcription factor NF-kB, as well as damage to the antioxidant system in obesity. Separately, a number of mechanisms of the stimulating effect of adipokines: leptin, adiponectin, chimerine, omentin 1, resistin, on the formation of oxidative stress have been noted. The ways of activating the polyol pathway, as well as diacyl-glycerol — protein kinase C — the signaling pathway of oxidative stress, the formation of mitochondrial dysfunction is described. As a result of which there is an excessive production of free radicals in insulin resistance, diabetes mellitus and macroand microvascular complications of diabetes. In addition, the influence of oxidative stress directly on the formation of cardiovascular diseases of atherosclerotic genesis, as well as arterial hypertension, has been shown.
1 January 2019 in Siberian Medical Review
KHKrasnoyarsk Regional Hospital
Krasnoyarsk Regional Hospital
PUProfessor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
+3
29 October 2021 in Meditsinskiy sovet = Medical Council
Introduction. One of their main aspects in the treatment of patients with bronchial asthma is maintaining adequate control over the course of the disease.The aim: to assess the level of control, the causes of the uncontrolled course of the disease and the quality of life in patients with severe bronchial asthma.Materials and methods. The study involved 160 patients with severe bronchial asthma taking basic anti-inflammatory therapy. The assessment of adherence to baseline therapy was assessed by questionnaires of patients with a modified Morisky-Green questionnaire and a test to assess adherence to inhalers (TAI). A quality of life questionnaire for patients with bronchial asthma (AQLQ) was used to assess quality of life.Results. It was revealed that all patients had reported daily symptoms and a daily need for short acting beta-agonists; 96.6% of the patients enrolled in the study had night awakenings and physical activity restriction. The survey of patients with the help of the Morisky-Green questionnaire showed that deliberate low adherence to therapy was noted in 45.6% of cases, which was formed due to inattention to the hours of medication – 67.1% and missing the drug in good health in 47.9% of patients. Low motivation and low awareness of their disease is recorded in 24.4% of patients.Conclusions. All patients did not achieve control of the disease. In half of patients with severe asthma, there is low deliberate adherence to basic anti-inflammatory therapy, which is formed mainly by missing the drug in good health and inattention to the hours of medication. Asthma symptoms have the greatest impact on the patient’s emotional state, physical activity, and overall quality of life.
1 January 2017 in Russian Journal of Cardiology
В статье описан клинический случай первичного амилоидоза с поражением сердца и перикарда, проявляющийся тяжелой, резистентной к лечению, сердечной недостаточностью. Демонстрация данного клинического случая свидетельствует о том, что диагностика амилоидоза и ведение пациентов, страдающих этим заболеванием, представляет собой непростую задачу в практике кардиолога. Связано это с его редкой распространенностью, отсутствием патогномоничных симптомов в клинической картине и при поздней диагностике отсутствием должного эффекта от проводимого современного лечения.
18 February 2026 in PULMONOLOGIYA
Uncontrolled asthma poses a widespread problem in Russia, fueled by the overuse of short-acting β 2 -agonists (SABA). The aim of the study titled “Clinical and demographic profiles of patients with uncontrolled asthma in Russia: multi-center observational registry study (ICEBERG)” is to investigate the clinical and demographic profile and treatment approaches in this patient population. Methods. An interim analysis of data from 2,024 adult patients with mild to moderate uncontrolled asthma was conducted. This multicenter observational retrospective-prospective study included two visits: baseline (collecting 52-week retrospective data and current status) and a 12-week follow-up visit to assess changes in therapy and clinical outcomes. Asthma control was assessed using Global Initiative for Asthma (GINA) criteria and the Asthma Control Questionnaire-5 (ACQ-5). Results. Patients with uncontrolled asthma predominantly exhibited a T2-high phenotype. A marked shift from SABA therapy to controller regimens was observed following the confirmation of uncontrolled disease: the proportion of patients on MART doubled (from 9.5% to 20.4%). This treatment optimization led to improved asthma control (full or partial control achieved in 70.6% of patients) and a significant reduction in the frequency and duration of exacerbations. The use of SABA as primary therapy remained a key risk factor for severe exacerbations. Conclusion. The consistent implementation of GINA strategies, in particular the transition to fixed-dose ICS/SABA combination therapy, the use of the MART regimen, and triple therapy, makes it possible to significantly improve the asthma control and reduce the risk of exacerbations in real-world clinical practice.
1 January 2020 in Siberian Medical Review
PUProfessor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
Professor V. F. Voino-Yasenetsky Krasnoyarsk State Medical University
+1